This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Skin of upper limb, including shoulder
CD2_BENIGN_SKIN_UPPERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D23
- Name in latin
- Neoplasma benignum cutis regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Skin of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Skin of upper limb, including shoulder
- Other benign neoplasms of skin
- Other benign neoplasms of skin
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 710 | 415 | 295 |
| Unadjusted period prevalence (%) | 0.14 | 0.14 | 0.13 |
| Median age at first event (years) | 51.29 | 49.67 | 53.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 628
- Matched controls
- 6280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
2411.9
323.0
511
11
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
99.6
129.7
140
18
21607
ICD-8 Finland
Benign neoplasm of skin, Extremitatis superioris
+∞
85.4
80
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.8
77.1
170
230
PJA12
NOMESCO Finland
Sentinel node biopsy
504.2
48.0
47
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
74.0
42.7
48
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
41.1
39
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
40.0
38
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
8.2
38.4
90
126
115
Kela drug reimbursment
Breast cancer
+∞
37.9
36
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
36.8
35
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.4
35.4
81
109
130
Kela drug reimbursment
Malignant tumour
+∞
33.6
32
*
A04AA02
ATC
granisetron; systemic, transdermal
173.8
32.0
33
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
29.4
28
*
H02AB02
ATC
dexamethasone; systemic
14.7
28.5
48
35
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.8
27.4
72
118
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
27.3
26
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
58.5
24.2
28
5
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
24.1
23
*
L57.0
ICD-10 Finland
Actinic keratosis
4.6
24.0
88
214
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.2
22.2
131
477
116
Kela drug reimbursment
Prostate cancer
+∞
22.0
21
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
22.0
21
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.5
21.5
29
11
XQ848
NOMESCO Finland
Dermatological photography
9.9
20.9
42
45
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
37.1
20.0
25
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.9
19
*
2166X
ICD-9 Finland
Benign neoplasm of skin, Skin of upper limb, including shoulder[YLÄRAAJAN IHON BEN KASV,TARK MÄÄRITT HYVÄNLAAT KASV]
+∞
19.9
19
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
10.6
19.6
38
38
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
19.4
113
405
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
27.0
19.3
26
10
WF002
NOMESCO Finland
Radical radiotherapy
72.1
18.8
21
*
JN4BD
NOMESCO Finland
Extensive body CT
5.0
18.4
61
133
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
45.4
18.3
22
5
SPAT1153
SPAT
Removal of sutures
2.3
18.0
219
1191
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.8
17
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
11.2
17.6
33
31
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
184.9
17.6
18
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
184.9
17.6
18
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
9.0
17.2
36
42
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
18.0
17.1
26
15
L03AA13
ATC
pegfilgrastim; parenteral
+∞
16.7
16
*
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
16.1
49
97
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
15.7
15
*
L02BA01
ATC
tamoxifen; oral
163.9
15.5
16
*
ZXC50
NOMESCO Finland
Cryotherapy
8.1
15.3
34
44
HA1AA
NOMESCO Finland
X-ray mammography
6.2
15.2
41
70
S18
ICPC
Laceration/cut
2.0
15.2
260
1617
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.7
15.0
38
60
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
13.6
14.8
25
19
127
Kela drug reimbursment
Transplant complication
13.6
14.8
25
19
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.6
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.2
14.6
27
25
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
9.1
13.6
28
32
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.6
13
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
13.6
13
*
9733
FHL
Excision of skin change in operating room or anesthesia
9.7
13.6
27
29
XQ845
NOMESCO Finland
Dermatoscopy
16.7
13.5
21
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
13.5
180
1000
ZX090
NOMESCO Finland
Other technic of radiotherapy
142.9
13.5
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.2
13.3
51
130
JN4AD
NOMESCO Finland
Body CT examination
5.3
13.1
40
80
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.1
13.0
41
85
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.2
13.0
31
45
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
51.1
12.9
15
*
L02BG04
ATC
letrozole; oral
10.8
12.8
24
23
L01BC06
ATC
capecitabine; oral
+∞
12.5
12
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
132.5
12.5
13
*
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
7.8
12.0
27
36
Z94.0
ICD-10 Finland
Kidney transplant status
12.0
11.9
21
18
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
11.5
11
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
11.5
11
*
Y77
ICPC
Malignant neoplasm prostate
+∞
11.5
11
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
11.5
11
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
11.5
11
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
11.5
11
*
L04AA06
ATC
mycophenolic acid; systemic
8.6
11.4
24
29
ZZR00
NOMESCO Finland
Flap of skin
17.4
11.2
17
10
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.3
11.1
26
37
B07.9
ICD-10 Finland
Verruca simplex
4.8
11.0
36
79
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
3.7
10.8
47
135
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
28.6
10.8
14
5
J01DB01
ATC
cefalexin; oral
1.9
10.7
500
4201
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
9.4
10.6
21
23
WZC30
NOMESCO Finland
Teaching
2.8
10.6
72
282
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
111.8
10.4
11
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
10.4
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.4
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
10.3
156
900
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
10.3
129
687
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
7.4
10.1
23
32
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
14.9
10.0
16
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
10.0
252
1727
NK6AN
NOMESCO Finland
Total body bone isotope imaging
55.9
9.7
11
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.3
9.6
18
18
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
7.7
9.5
21
28
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
101.5
9.4
10
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
17.9
9.4
14
8
ZQZ00
NOMESCO Finland
Treatment of several skin areas
+∞
9.4
9
*
2166G
ICD-9 Finland
Benign neoplasm of skin, Skin of upper limb, including shoulder[YLÄRAAJAN IHON BEN KASV,MUU MÄÄR HYVÄNLAAT KASV]
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
9.4
9
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
9.4
9
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
9.4
9
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
13.9
9.2
15
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
9.2
38
105
A12AA04
ATC
calcium carbonate; oral
8.5
9.1
19
23
TQW80
NOMESCO Finland
Local dermatologic skincare
4.6
9.1
30
67
ZXA00
NOMESCO Finland
Right side
1.9
9.0
165
1013
L04AD01
ATC
ciclosporin; systemic
7.0
8.9
21
31
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
5.5
8.8
25
47
L02AE02
ATC
leuprorelin; implant, parenteral
10.9
8.8
16
15
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
9.7
8.8
17
18
L91.0
ICD-10 Finland
Hypertrophic scar
8.4
8.6
18
22
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
8.5
78
361
Z51.5
ICD-10 Finland
Palliative care
5.8
8.5
23
41
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
27.9
8.5
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
91.2
8.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.4
8.3
29
69
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
4.7
8.3
27
60
A04AA01
ATC
ondansetron; systemic, rectal
4.7
8.3
27
60
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
33.8
8.1
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.9
8.0
25
53
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.7
7.9
19
29
L82
ICD-10 Finland
Seborrhoeic keratosis
2.0
7.9
103
555
J01DA01
ATC
[U] cefalexin; systemic
1.6
7.8
380
3052
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.6
7.8
15
16
TK800
NOMESCO Finland
Hemodialysis
5.7
7.7
21
38
HAC20
NOMESCO Finland
Total mastectomy
45.5
7.7
9
*
L03AA02
ATC
filgrastim; parenteral
45.5
7.7
9
*
ZX120
NOMESCO Finland
Intravenous
2.7
7.7
52
204
B01AB10
ATC
tinzaparin; parenteral
3.4
7.6
35
107
ZZA00
NOMESCO Finland
Split skin graft
5.7
7.4
20
36
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.7
7.3
23
50
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
7.2
21
42
A11CC03
ATC
alfacalcidol; systemic
5.4
7.1
20
38
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
7.1
20
38
WX110
NOMESCO Finland
Local anesthesy
1.6
7.0
396
3261
UJF32
NOMESCO Finland
Coloscopy
1.7
6.9
147
938
L04AX01
ATC
azathioprine; systemic
3.1
6.8
35
117
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
16.9
6.8
10
6
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
16.9
6.8
10
6
ZXA05
NOMESCO Finland
Left side
1.7
6.7
144
922
B05DA
ATC
Isotonic solutions
10.2
6.6
12
12
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
6.5
59
272
N02AA05
ATC
oxycodone; systemic
2.3
6.5
59
272
R4110
NOMESCO Finland
Physiotherapy
1.7
6.4
142
914
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
6.4
34
116
L01BB01
ATC
NA
70.5
6.4
7
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
70.5
6.4
7
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
6.4
104
608
JN4CD
NOMESCO Finland
Very extensive body CT
6.0
6.3
16
27
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
6.3
41
159
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
6.3
76
399
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.8
6.2
16
28
J05AB11
ATC
valaciclovir; oral
2.0
6.1
77
411
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
6.1
75
397
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
8.7
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
77
261
3.19
18.07
3.1
1.5
18.4
4.0
ug/l
0.56
59
193
32
76
4.36
12.57
1.3
1.2
—
—
—
0
0
325
2371
1.68
10.31
4.3
3.7
—
—
—
0
0
303
2176
1.68
10.16
6.6
3.8
35.7
36.1
g/l
0.55
277
2024
393
3043
1.65
9.68
12.1
6.5
4.1
4.2
e9/l
0.51
352
2658
503
4177
1.70
9.22
9.5
5.3
76.6
74.8
u/l
0.56
476
3867
343
2597
1.62
9.01
6.7
3.8
10.4
11.8
umol/l
2.54
325
2440
29
86
3.47
8.43
7.8
5.6
236.5
463.0
iu/ml
—
6
13
88
467
2.01
7.86
3.9
3.0
244.9
242.5
u/l
0.06
81
442
24
70
3.51
7.17
3.0
2.3
—
554.1
—
0
9
304
2326
1.54
7.09
2.5
2.3
79.5
77.3
nmol/l
0.68
276
2063
64
314
2.14
7.04
1.9
1.5
—
—
—
0
0
326
2546
1.52
6.84
10.1
5.6
1.2
1.2
mmol/l
0.44
275
2179
83
459
1.92
6.58
2.3
3.2
171.3
205.6
ng/l
0.30
72
425
117
727
1.73
6.34
5.1
2.7
0.8
0.8
mmol/l
0.42
111
675
9
5
18.20
6.27
1.1
1.0
—
—
—
0
0
230
1717
1.50
5.75
3.9
2.0
2.3
2.4
mmol/l
0.70
202
1442
166
1164
1.56
5.52
2.7
2.0
—
—
—
0
0
292
2301
1.46
5.50
9.4
5.1
1.2
1.2
mmol/l
0.80
269
2055
380
3147
1.45
5.49
6.3
4.2
6.9
6.7
mmol/l
1.11
359
2914
27
101
2.74
5.39
3.8
3.1
4.2
4.3
e9/l
0.05
27
101
27
102
2.71
5.30
4.5
3.5
56.3
57.5
%
0.15
27
102
28
109
2.63
5.19
2.0
2.1
132.2
129.5
g/l
0.18
21
80
639
5923
1.79
5.18
20.3
13.7
139.7
139.7
mmol/l
0.11
630
5749
104
662
1.67
5.13
3.3
2.5
23.5
24.2
%
0.21
87
559
68
385
1.85
5.03
2.9
2.0
0.2
0.2
g/l
0.33
63
352
121
809
1.60
4.90
3.0
2.3
13.3
13.8
umol/l
0.30
114
746
639
5944
1.75
4.83
20.5
13.8
4.0
4.0
mmol/l
0.02
630
5760
109
718
1.61
4.69
3.1
2.4
2.3
2.3
g/l
0.44
102
669
91
574
1.67
4.65
2.0
1.8
—
—
—
0
0
152
1088
1.51
4.53
3.7
3.8
159.4
383.7
ng/l
1.14
115
823
90
571
1.66
4.50
2.0
1.7
—
—
—
0
0
239
1873
1.42
4.42
4.5
2.9
—
—
—
0
0
31
138
2.30
4.37
2.0
2.2
90.5
90.0
%
0.03
31
130
619
5748
1.60
4.24
18.9
11.5
22.1
22.6
mg/l
0.15
499
4373
189
1432
1.44
4.18
3.6
2.3
4786.0
7173.6
umol/l
0.31
159
1244
189
1436
1.43
4.11
3.8
2.7
0.2
0.4
e6/l
1.69
141
1068
119
832
1.52
3.94
2.2
1.8
—
—
—
0
0
39
200
2.01
3.90
1.3
1.7
1.5
1.5
g/l
0.09
34
178
10
24
4.21
3.90
1.5
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
139
2.21
3.88
4.1
2.4
0.3
0.3
u/ml
0.57
17
81
161
1208
1.43
3.72
1.7
1.6
1.0
1.0
mg/l
0.02
126
909
86
572
1.57
3.56
8.3
6.9
1.1
1.4
mmol/l
0.32
65
448
27
127
2.17
3.40
1.8
1.5
—
—
—
0
0
220
1764
1.36
3.40
4.0
2.7
27.6
31.7
u/l
1.96
210
1678
22
95
2.36
3.37
2.0
1.6
—
—
—
0
0
21
89
2.40
3.34
1.3
1.6
—
—
—
0
0
67
435
1.60
3.09
5.1
3.7
150.7
86.2
ng/l
1.50
62
389
474
4279
1.32
3.08
5.2
4.1
12.9
11.4
mm/h
1.48
437
3932
10
29
3.48
3.05
1.2
2.7
356.9
681.4
u/ml
—
10
29
281
2372
1.31
2.96
2.0
2.0
92.6
96.0
pmol/l
0.59
139
1181
522
4789
1.34
2.96
22.0
13.9
13.7
13.6
%
0.99
515
4672
172
1360
1.35
2.85
2.4
2.1
2.7
2.9
mg/l
0.78
153
1153
25
124
2.05
2.79
1.6
1.2
—
—
—
0
0
649
6195
1.55
2.78
13.1
8.6
25.8
26.2
u/l
0.19
635
5938
16
66
2.46
2.72
2.4
1.6
—
—
—
0
0
21
101
2.11
2.55
2.0
1.6
—
—
—
0
0
73
507
1.49
2.52
4.1
2.7
—
—
—
0
0
6
12
5.03
2.40
1.3
1.1
—
—
—
0
0
6
12
5.03
2.40
1.3
1.1
—
—
—
0
0
65
446
1.50
2.39
2.8
2.1
59.4
67.8
ml/min/173m2
0.76
22
188
104
786
1.38
2.29
2.2
1.8
29.3
29.7
s
0.34
99
756
115
884
1.36
2.28
2.7
2.5
0.9
1.1
e6/l
0.48
68
495
13
54
2.43
2.21
2.3
1.6
—
—
—
0
0
420
3814
1.25
2.20
3.2
3.0
48.1
44.0
u/l
0.46
398
3560
78
566
1.42
2.18
4.8
2.3
5.8
8.6
umol/l
1.69
71
481
28
161
1.77
2.09
5.1
4.2
3.9
3.9
mmol/l
0.07
28
153
20
103
1.97
2.07
1.5
1.3
—
—
—
0
0
20
103
1.97
2.07
1.5
1.3
—
—
—
0
0
6
15
4.02
2.04
1.3
1.1
—
—
—
0
0
6
15
4.02
2.04
1.3
1.1
—
—
—
0
0
485
4500
1.25
1.99
4.2
3.8
14.8
14.8
pmol/l
0.18
447
4101
571
5402
1.29
1.97
5.0
4.6
1.9
2.1
mu/l
0.58
529
4940
19
98
1.96
1.97
1.3
1.2
—
—
—
0
0
27
157
1.75
1.95
2.8
3.2
—
—
—
0
0
17
85
2.02
1.91
1.6
1.4
—
—
—
0
0
14
65
2.18
1.89
1.2
1.3
—
—
—
0
0
29
174
1.70
1.89
1.5
1.6
0.0
0.1
iu/ml
—
6
30
18
93
1.96
1.86
1.3
1.2
384.4
265.1
u/ml
0.90
11
54
205
1747
1.24
1.86
2.2
2.2
284.2
291.6
u/l
0.02
192
1635
66
481
1.41
1.82
5.6
3.1
1.9
2.0
mmol/l
0.08
55
390
199
1694
1.24
1.82
2.9
2.2
63.1
57.2
u/l
0.27
190
1561
66
485
1.40
1.75
5.5
3.1
5.8
5.8
kpa
0.07
66
470
184
1562
1.24
1.72
1.7
1.7
1.4
1.4
mmol/l
0.30
157
1311
5
13
3.86
1.71
2.8
4.8
—
—
—
0
0
126
1023
1.28
1.71
1.6
1.5
—
—
—
0
0
44
302
1.49
1.67
1.7
1.4
—
—
—
0
0
13
62
2.12
1.66
1.2
1.4
—
—
—
0
0
56
404
1.42
1.65
4.1
2.4
5.5
4.6
kpa
1.18
56
390
47
329
1.46
1.63
3.1
2.7
127.3
129.8
g/l
0.28
47
322
102
814
1.30
1.59
2.8
2.7
1.7
3.0
e6/l
1.36
55
427
53
386
1.40
1.50
4.0
1.6
64.5
67.9
g/l
2.00
45
349
596
5718
1.26
1.50
4.9
4.5
6.0
5.9
mmol/l
0.27
556
5203
14
72
1.96
1.49
1.2
1.4
—
—
—
0
0
10
45
2.24
1.47
2.9
2.0
—
—
—
0
0
5
17
2.95
1.36
1.8
1.3
—
—
—
0
0
10
47
2.14
1.34
5.3
1.6
—
—
—
0
0
9
42
2.16
1.34
2.8
1.9
—
—
—
0
0
9
42
2.16
1.34
3.7
1.1
—
—
—
0
0
16
90
1.80
1.34
1.3
1.4
—
—
—
0
0
27
178
1.54
1.28
1.8
1.8
—
—
—
0
0
239
2137
1.18
1.27
3.8
3.5
31.0
55.1
ng/l
0.75
169
1438
6
25
2.41
1.24
1.3
1.3
15.0
15.3
ug/l
—
6
25
40
543
0.72
1.21
2.0
1.7
—
—
—
0
0
11
57
1.94
1.17
4.5
2.0
33.7
33.3
pg
0.18
11
57
17
102
1.68
1.17
1.9
1.5
—
—
—
0
0
206
1834
1.17
1.14
4.7
4.0
7.9
8.2
mg/mmol
0.03
133
1143
168
1474
1.18
1.11
5.5
3.7
0.0
0.0
estimate
0.88
59
473
115
976
1.21
1.09
3.2
2.1
2.5
2.4
mmol/l
1.50
99
837
5
22
2.28
1.03
1.2
1.2
129.6
115.1
%
—
5
17
5
22
2.28
1.03
2.0
1.5
—
—
—
0
0
273
2501
1.15
1.02
3.3
2.7
147.6
110.1
ug/l
1.62
258
2304
14
83
1.70
1.02
2.0
1.4
—
—
—
0
0
35
258
1.38
0.99
3.3
2.2
1.4
1.3
%
0.39
35
258
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
48
373
1.31
0.97
8.3
2.3
1.2
1.2
mmol/l
0.00
43
309
12
69
1.75
0.97
1.2
1.3
—
—
—
0
0
208
1876
1.15
0.97
3.9
3.2
7.3
7.5
mmol/l
0.46
173
1580
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
41
314
1.32
0.92
4.1
3.5
1.4
1.9
mmol/l
0.49
33
235
121
1050
1.18
0.92
1.8
1.7
1303.6
1189.8
nmol/l
0.60
92
781
598
5812
1.18
0.89
4.8
4.4
1.4
1.5
mmol/l
0.91
558
5354
178
1597
1.15
0.89
3.0
2.9
1684.1
1281.2
ng/l
0.43
153
1345
8
42
1.91
0.88
1.8
1.2
—
—
—
0
0
8
42
1.91
0.88
1.8
1.2
—
—
—
0
0
8
42
1.91
0.88
1.8
1.2
—
—
—
0
0
105
903
1.19
0.88
1.5
1.4
—
—
—
0
0
11
65
1.70
0.82
1.9
1.4
—
—
—
0
0
83
705
1.20
0.81
31.5
25.0
1.2
1.3
inr
0.16
14
100
11
176
0.62
0.80
1.1
1.3
98.4
271.0
miu/ml
—
5
86
559
5418
1.15
0.80
16.7
10.3
80.2
81.6
ml/min/173m2
0.71
452
4331
8
48
1.67
0.79
2.0
1.6
—
—
—
0
0
14
90
1.57
0.78
3.4
2.3
16.5
16.4
%
—
9
46
38
297
1.30
0.77
1.9
1.6
—
—
—
0
0
87
748
1.19
0.75
12.0
6.6
—
—
—
0
0
19
133
1.44
0.74
1.2
1.4
323.7
319.9
ug/g
0.04
14
76
27
202
1.35
0.73
3.7
2.2
856.3
514.1
ug/l
0.29
27
189
13
84
1.56
0.72
1.6
1.3
—
0.6
nmol/l
—
0
9
11
68
1.63
0.72
3.1
2.0
13.3
13.2
%
0.11
11
68
609
5951
1.16
0.72
5.4
5.0
2.7
2.8
mmol/l
1.71
570
5482
5
26
1.93
0.70
1.2
1.1
62.8
192.3
iu/ml
—
5
26
26
195
1.35
0.70
1.3
1.4
—
—
—
0
0
13
85
1.54
0.69
1.6
1.3
0.7
0.6
nmol/l
0.89
13
79
9
59
1.53
0.68
1.4
1.1
—
—
—
0
0
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
7
43
1.63
0.67
1.9
1.5
—
—
—
0
0
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
8
129
0.62
0.64
1.5
1.2
—
8.8
—
0
10
18
129
1.41
0.64
1.1
1.3
15.5
10.3
u/l
0.50
12
104
5
30
1.67
0.61
1.0
1.1
1194.6
1849.7
miu/ml
—
5
30
5
30
1.67
0.61
2.6
1.7
—
—
—
0
0
8
50
1.61
0.61
1.8
1.4
—
—
—
0
0
62
723
0.84
0.61
1.6
1.8
1.3
1.5
%
1.80
53
637
295
2787
1.10
0.60
5.6
4.7
0.0
0.0
estimate
0.50
59
481
8
51
1.57
0.60
1.1
1.1
—
—
—
0
0
151
1378
1.12
0.60
1.4
1.5
20.6
20.9
nmol/l
0.09
131
1181
8
52
1.54
0.59
3.9
3.8
—
—
—
0
0
115
1032
1.14
0.59
1.3
1.3
29.9
34.3
iu/ml
0.13
34
332
298
2820
1.10
0.59
4.5
3.4
0.0
0.0
estimate
0.50
58
476
48
402
1.21
0.58
1.2
1.2
198.4
126.5
iu/ml
0.30
11
167
21
158
1.34
0.57
1.3
1.3
—
—
—
0
0
6
37
1.63
0.55
1.0
1.0
357.3
322.2
ng/l
—
6
24
6
37
1.63
0.55
1.0
1.0
39.5
50.4
ng/l
—
6
22
9
60
1.51
0.54
1.4
1.1
—
—
—
0
0
9
60
1.51
0.54
1.4
1.1
—
—
—
0
0
597
5852
1.13
0.54
4.9
4.5
4.6
4.7
mmol/l
1.84
562
5420
6
40
1.50
0.51
1.5
1.9
20.7
20.7
nmol/l
—
6
34
39
325
1.21
0.51
3.2
1.9
—
—
—
0
0
26
208
1.26
0.48
4.9
3.9
25.0
24.8
mmol/l
0.14
26
196
25
199
1.27
0.48
2.1
1.6
—
—
—
0
0
572
5605
1.11
0.47
4.4
4.0
1.3
1.3
mmol/l
0.23
532
5127
14
102
1.38
0.47
1.4
1.2
—
—
—
0
0
12
86
1.40
0.44
1.2
1.1
—
—
—
0
0
17
130
1.32
0.44
2.6
2.9
23.3
25.0
mmol/l
1.05
12
115
54
471
1.16
0.44
3.6
2.0
55.7
34.1
u/l
0.65
43
388
20
157
1.28
0.44
1.4
1.4
—
—
—
0
0
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
8
56
1.43
0.42
1.5
1.1
—
—
—
0
0
8
57
1.41
0.42
1.5
1.1
—
—
—
0
0
8
57
1.41
0.42
1.5
1.1
—
—
—
0
0
554
5431
1.09
0.42
6.5
5.8
40.8
39.7
mmol/mol
1.47
516
5053
10
70
1.43
0.42
1.1
1.0
1.5
1.5
g/l
—
10
62
290
2776
1.08
0.41
4.5
3.4
0.0
0.0
estimate
0.00
59
485
0
17
0.00
0.40
0.0
3.5
—
—
—
0
0
0
17
0.00
0.40
0.0
3.5
—
—
—
0
0
15
115
1.31
0.39
1.3
1.7
—
—
—
0
0
57
508
1.13
0.36
2.7
1.8
333.8
370.4
nmol/l
0.80
52
465
12
90
1.34
0.36
1.3
1.2
—
—
—
0
0
177
1673
1.08
0.36
5.2
3.8
6.5
1.9
ug/l
0.70
155
1498
227
2169
1.07
0.34
4.8
3.5
—
—
—
0
0
6
47
1.28
0.32
1.8
1.2
—
—
—
0
0
25
212
1.19
0.30
2.6
1.7
—
—
—
0
0
23
271
0.84
0.30
3.3
2.7
0.9
0.2
e6/l
0.66
23
259
18
148
1.22
0.29
4.4
1.4
40.1
38.3
g/l
1.87
13
127
21
176
1.20
0.29
4.0
1.4
9.3
10.6
g/l
0.71
14
150
19
160
1.19
0.25
4.3
1.5
0.6
0.5
g/l
0.08
13
143
12
148
0.81
0.24
1.4
1.4
—
—
—
0
0
9
76
1.19
0.24
1.2
1.2
—
—
—
0
0
27
306
0.88
0.23
1.6
1.3
—
—
—
0
0
24
209
1.15
0.23
1.3
1.8
—
—
—
0
0
17
200
0.85
0.23
1.8
2.1
—
—
—
0
0
18
153
1.18
0.22
1.4
1.3
—
—
—
0
0
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
542
5352
1.05
0.22
20.3
12.7
40.4
40.2
%
0.27
374
3842
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
376
3683
1.04
0.22
2.9
3.0
—
—
—
0
0
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.0
—
0
5
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.0
—
1.2
—
0
14
10
121
0.82
0.18
1.5
1.4
—
—
—
0
0
10
121
0.82
0.18
1.5
1.4
—
—
—
0
0
10
121
0.82
0.18
1.5
1.4
—
—
—
0
0
10
121
0.82
0.18
1.5
1.4
—
—
—
0
0
32
291
1.10
0.17
1.0
1.0
—
—
—
0
0
21
186
1.13
0.17
4.1
1.5
2.6
3.1
g/l
1.57
15
143
136
1311
1.05
0.16
5.2
3.8
1.0
1.0
kg/l
0.00
11
172
21
187
1.13
0.16
1.8
1.5
0.2
0.2
g/l
0.17
21
180
27
245
1.11
0.15
2.4
2.2
33.9
39.4
u/l
0.97
22
214
135
1304
1.04
0.15
1.3
1.2
0.7
1.8
u/ml
2.40
37
365
67
705
0.95
0.14
5.2
4.6
35.2
32.2
%
1.47
45
456
104
1004
1.04
0.12
1.3
1.3
4.4
10.9
u/ml
1.27
35
389
61
640
0.95
0.12
2.6
2.1
—
—
—
0
0
28
259
1.08
0.11
3.6
1.8
—
—
—
0
0
17
153
1.11
0.11
2.4
2.1
7910.8
3875.1
u/l
—
7
59
17
154
1.11
0.10
1.1
1.1
—
—
—
0
0
21
195
1.08
0.08
4.1
1.5
—
—
—
0
0
21
195
1.08
0.08
4.1
1.5
3.7
3.9
g/l
0.24
15
139
21
195
1.08
0.08
4.1
1.5
7.5
7.6
g/l
0.12
15
148
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
7
82
0.85
0.07
1.0
1.0
—
—
—
0
0
21
196
1.07
0.07
2.2
1.5
—
—
—
0
0
7
84
0.83
0.07
1.0
1.1
—
—
—
0
0
9
105
0.86
0.06
1.4
1.6
—
—
—
0
0
122
1198
1.02
0.06
1.5
1.7
70588724.1
19270213.2
pmol/l
0.32
102
986
12
131
0.91
0.05
1.2
1.2
22.3
73.1
e6/l
—
7
106
12
131
0.91
0.05
1.2
1.3
3.9
1020.5
e6/l
—
7
108
133
1349
0.98
0.04
4.6
3.7
24.4
24.0
%
0.10
61
612
17
180
0.94
0.04
1.2
1.1
—
—
—
0
0
17
179
0.95
0.03
1.2
1.1
—
—
—
0
0
22
228
0.96
0.02
1.6
1.5
—
—
—
0
0
95
943
1.01
0.01
3.2
2.6
0.8
0.7
ug/l
0.07
65
616
58
574
1.01
0.00
2.6
2.0
—
—
—
0
0
13
134
0.97
0.00
1.5
1.5
—
—
—
0
0
16
157
1.02
0.00
2.4
2.4
94.7
86.6
ug/min
—
9
92
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
9
99
0.91
0.00
2.1
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
7
77
0.91
0.00
1.0
1.1
112.4
119.6
%
—
7
70
7
79
0.88
0.00
1.6
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
7
77
0.91
0.00
1.1
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SKIN_UPPERLIMB_EXALLC – Benign neoplasm: Skin of upper limb, including shoulder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).